NCT06152562Completed
Evaluation of Platelet Therapy Response in Left Ventricular Assist Device Patients
Source: ClinicalTrials.gov · Last updated 30 Nov 2023
Brief summary (registry, in English)
The aim of this study is to evaluate the incidence of any hemocompatibility related adverse event (HRAE) after LVAD placement in patients responsive to a standard aspirin dose using point-of-care platelet inhibition monitoring compared with initial non-responders who were then up-titrated to achieve a therapeutic response using individualized acetylsalicylic acid (ASA) therapy. Second, to investigate whether patients exhibit temporal changes in ASA sensitivity during LVAD support.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 24 (actual)
- First submitted
- 10 Dec 2021
- Start date
- 6 Dec 2021
- Primary completion date
- 28 Nov 2023
- Lead sponsor
- Medical University of Vienna
- Diseases
- Heart failure
- NCT number
- NCT06152562
- EudraCT number
- 2021-004921-62
What you commit to
- Study type: Observational
- Participants enrolled: 24
- From 6 Dec 2021 to the primary completion date, 28 Nov 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- No ASA therapy
Age
- Age: \<18 or \>75 years
Other
- Inability to provide informed consent
Who the study is looking for
- The participants will be recipients of the routinely used HeartMate 3 (Abbott, Abbott Park, IL) or HVAD (Medtronic Inc., Dublin, Ireland) system implanted at the Medical University of Vienna, which are able and willing to understand and sign the informed consent form, and which do not meet any exclusion criteria.
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Medical University of Vienna Coordinator of this site? Confirm its status | Vienna | Austria | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.